EU regulator reviewing possible links between Johnson & Johnson coronavirus vaccine and blood clots

Coronavirus, Europe, Health, Janssen, Science, Side Effects, Vaccine

Europe’s drugs regulator is reviewing possible links between blood clots and Johnson & Johnson’s coronavirus vaccine. It comes after four serious cases of rare clots with low platelets were reported after the COVID-19 jab, one of which was fatal, according to the European Medicines Agency (EMA).

The Johnson & Johnson (also known as Janssen) vaccine, which has proved 67% effective in preventing coronavirus and completely effective at preventing hospital admissions and death from the virus during trials, is currently only used in the USA, under an emergency use authorisation.

Sky News report



** This post was originally published on April 9, 2021 **